1 minute read
From the President
Kevin London - MANZSNM President
Hello friends,
Welcome to the last edition of the Gamma Gazette for 2022. Another year has flown by.
Our profession continues to flourish and this year it was nice to see an enthusiastic return to face-to-face interactions. The ANZSNM Council and the various sub-committees continue to work hard to pull together more educational and networking opportunities. It goes without saying that we are all looking forward to our flagship Annual Scientific Meeting in Adelaide next year. Hope to see you there.
Coming back to the latest Gamma Gazette issue, having celebrated 30 years of PET in Australia we now turn our attention to the future. Theranostics is an area set to have a substantial impact on the management of patients with cancer. Advances in this field have been led by researchers in our part of the world, many of whom are ANZSNM members. I find it amazing and inspirational to look around at our ANZSNM events and see the faces of the highly influential researchers who have published groundbreaking studies in high impact journals. This Gamma Gazette issue looks to the future and speaks of the prominent role theranostics will have in our profession, and the important role we all have in delivering this life saving treatment to patients who will benefit from it.
As the membership renewal period for 2023 will close on the 31st of December, I would urge you to consider renewing and continuing to support your Society and the profession.
Lastly, I would like to wish you a wonderful festive season and look forward to talking to you in the new year.
Kia kaha, Kevin
